SCHEDULE 13G Filed 2026-07-31 Event — SEC 0002100119-26-001319 →

VANGUARD CAPITAL MANAGEMENT LLC → Anavex Life Sciences Corp AVXL

Stake: — Shares: — Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

13 filings by this filer

12 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 15.60

14,140,060 shares short · -0.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $990K

Point72 Asset Mgmt

Other Filings by VANGUARD CAPITAL MANAGEMENT LLC

Filed	Form	Issuer	Stake	Shares
2026-07-31	SCHEDULE 13G	Arhaus Inc	—	—	view →
2026-07-31	SCHEDULE 13G	ARMOUR Residential REIT Inc	—	—	view →
2026-07-31	SCHEDULE 13G	ACV Auctions Inc	—	—	view →
2026-07-31	SCHEDULE 13G	Altisource Portfolio Solutions SA	—	—	view →
2026-07-31	SCHEDULE 13G	Ambarella Inc	—	—	view →
2026-07-31	SCHEDULE 13G	Antero Resources Corp	—	—	view →
2026-07-31	SCHEDULE 13G	Arbor Realty Trust Inc	—	—	view →
2026-07-31	SCHEDULE 13G	Avanos Medical Inc	—	—	view →
2026-07-31	SCHEDULE 13G	Andersons Inc/The	—	—	view →
2026-07-31	SCHEDULE 13G	Brady Corp	—	—	view →
2026-07-31	SCHEDULE 13G	Brandywine Realty Trust	—	—	view →
2026-07-31	SCHEDULE 13G	Ares Commercial Real Estate Corp	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →